» Articles » PMID: 10866444

Assessment of Thymic Output in Adults After Haematopoietic Stem-cell Transplantation and Prediction of T-cell Reconstitution

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2000 Jun 24
PMID 10866444
Citations 164
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The potential benefits of haematopoietic stem-cell transplantation are tempered by the depletion of T-cells accompanying this procedure. We used a new technique which quantifies the excisional DNA products of T-cell-receptor (TCR) gene rearrangement to measure thymic output directly in patients with multiple myeloma, and thus assessed the contribution of the thymus to immune recovery after transplantation.

Methods: We studied 40 patients, 34-66 years of age, who had been randomly assigned myeloablative chemotherapy and autologous peripheral-blood haematopoietic stem-cell transplantation with unmanipulated grafts or grafts enriched for CD34 stem cells. CD4 and CD8 T-cell counts were measured, thymic output was estimated serially until 2 years after transplantation, and percentages of naive T-cells were measured.

Findings: The production of substantial numbers of new naive T cells by the thymus could be detected by 100 days post-transplant; there was a significant inverse relation between age and recovery of new T cells. In the CD34-unselected group, numbers of TCR-rearrangement excision circles returned to baseline after 2 years, whereas in the CD34-selected group, numbers at 2 years were significantly higher than both baseline numbers (p=0.004), and 2-year numbers in the unselected group (p=0.046). Increased thymic output correlated with, and was predictive of, increased naive T-cell numbers and broader T-cell-receptor repertoires.

Interpretation: Our results provide evidence that the adult thymus contributes more substantially to immune reconstitution after haematopoietic stem-cell transplantation than was previously thought, and therefore could be a target for therapeutic intervention.

Citing Articles

Newborn screening for SCID: the very first prospective pilot study from Türkiye.

Haskologlu S, Kocak S, Tufan L, Aksoy F, Bastug D, Oner D Front Immunol. 2024; 15:1384195.

PMID: 39483481 PMC: 11526446. DOI: 10.3389/fimmu.2024.1384195.


Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy.

Hughes C, Shah G, Paul B Front Oncol. 2024; 14:1373548.

PMID: 38601770 PMC: 11004402. DOI: 10.3389/fonc.2024.1373548.


Primary and secondary defects of the thymus.

Dinges S, Amini K, Notarangelo L, Delmonte O Immunol Rev. 2024; 322(1):178-211.

PMID: 38228406 PMC: 10950553. DOI: 10.1111/imr.13306.


Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation.

Stern L, McGuire H, Avdic S, Blyth E, Gottlieb D, Patrick E Clin Transl Immunology. 2023; 12(12):e16815.

PMID: 38034080 PMC: 10684332. DOI: 10.1002/cti2.1473.


Impact of Age, Sex, and Genetic Diversity in Murine Models of the Hematopoietic Acute Radiation Syndrome (H-ARS) and the Delayed Effects of Acute Radiation Exposure (DEARE).

Orschell C, Wu T, Patterson A Curr Stem Cell Rep. 2023; 8(3):139-149.

PMID: 36798890 PMC: 9928166. DOI: 10.1007/s40778-022-00214-z.